Skip to main content

Advertisement

Log in

Birt–Hogg–Dubé syndrome and the skin

  • Original Article
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Birt-Hogg-Dubé syndrome (MIM #135150) is characterized by the development of benign skin tumours called fibrofolliculomas, pulmonary cysts that may lead to pneumothorax and a high risk of developing kidney cancer. BHD is caused by mutations affecting the highly conserved protein folliculin (FLCN), which probably has a role in intracellular transport. Most of the research effort directed towards BHD has focused on understanding how loss of FLCN causes kidney cancer. The cutaneous manifestations have received comparatively little attention. Although understandable, it is unfortunate, as the fibrofolliculomas are highly accessible and thus potentially are an excellent system for trying to understand the basic pathobiology of BHD. Also, patients can be very much burdened by the cosmetic consequences of having hundreds of facial skin tumours. Our lack of insight into what drives fibrofolliculoma growth translates into a very limited therapeutic arsenal. Thus, paying attention to fibrofolliculomas has both basic science and practical benefits. In this review, we will discuss the state of the art regarding our understanding of fibrofolliculoma pathogenesis and indicate future directions for research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Nookala RK, Langemeyer L, Pacitto A, Ochoa-Montaño B, Donaldson JC, Blaszczyk BK, Chirgadze DY, Barr FA, Bazan JF, Blundell TL (2012) Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer. Open Biol 2(8):120071. doi:10.1098/rsob.120071

    Google Scholar 

  2. Nahorski MS, Seabra L, Straatman-Iwanowska A, Wingenfeld A, Reiman A, Lu X, Klomp JA, Teh BT, Hatzfeld M, Gissen P, Maher ER (2012) Folliculin interacts with p0071 (Plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis. Hum Mol Genet 21(24):5268–5279

    Google Scholar 

  3. Preston RS, Philp A, Claessens T, Gijezen L, Dydensborg AB, Dunlop EA, Harper KT, Brinkhuizen T, Menko FH, Davies DM, Land SC, Pause A, Baar K, van Steensel MA, Tee AR (2011) Absence of the Birt–Hogg–Dube gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Oncogene 30(10):1159–1173

    Article  PubMed  CAS  Google Scholar 

  4. Gaur K, Li J, Wang D, Dutta P, Yan SJ, Tsurumi A, Land H, Wu G, Li WX. (2012) The Birt–Hogg–Dube tumor suppressor Folliculin negatively regulates ribosomal RNA synthesis. Hum Mol Genet 22(2):284–299

    Google Scholar 

  5. Chen J, Futami K, Petillo D, Peng J, Wang P, Knol J, Li Y, Khoo SK, Huang D, Qian CN, Zhao P, Dykema K, Zhang R, Cao B, Yang XJ, Furge K, Williams BO, Teh BT (2008) Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS ONE 3(10):e3581

    Article  PubMed  Google Scholar 

  6. Gascue C, Katsanis N, Badano JL (2011) Cystic diseases of the kidney: ciliary dysfunction and cystogenic mechanisms. Pediatr Nephrol 26(8):1181–1195

    Article  PubMed  Google Scholar 

  7. Foucar K, Rosen T, Foucar E, Cochran RJ (1981) Fibrofolliculoma: a clinicopathologic study. Cutis 28(4):429–432

    PubMed  CAS  Google Scholar 

  8. Kahle B, Hellwig S, Schulz T (2001) Multiple mantleomas in Birt–Hogg–Dube syndrome: successful therapy with CO2 laser. Hautarzt. 52(1):43–46

    Article  PubMed  CAS  Google Scholar 

  9. Mantleoma Steffen C (1993) A benign neoplasm with mantle differentiation. Am J Dermatopathol 15(4):306–310

    Article  Google Scholar 

  10. Croyle MJ, Lehman JM, O’Connor AK, Wong SY, Malarkey EB, Iribarne D, Dowdle WE, Schoeb TR, Verney ZM, Athar M, Michaud EJ, Reiter JF, Yoder BK (2011) Role of epidermal primary cilia in the homeostasis of skin and hair follicles. Development 138(9):1675–1685

    Article  PubMed  CAS  Google Scholar 

  11. Nelson AM, Gilliland KL, Cong Z, Thiboutot DM (2006) 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol 126(10):2178–2189

    Article  PubMed  CAS  Google Scholar 

  12. van Steensel MA, Verstraeten VL, Frank J, Kelleners-Smeets NW, Poblete-Gutierrez P, Marcus-Soekarman D, Bladergroen RS, Steijlen PM, van Geel M (2007) Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt–Hogg–Dube patients. J Invest Dermatol 127(3):588–593

    Article  PubMed  Google Scholar 

  13. Li S, Thangapazham RL, Wang JA, Rajesh S, Kao TC, Sperling L, Moss J, Darling TN (2011) Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis. Nat Commun 2:235

    Article  PubMed  Google Scholar 

  14. Rasanen K, Vaheri A (2010) Activation of fibroblasts in cancer stroma. Exp Cell Res 316(17):2713–2722

    Article  PubMed  Google Scholar 

  15. Merrill BJ, Gat U, DasGupta R, Fuchs E (2001) Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev 15(13):1688–1705

    Article  PubMed  CAS  Google Scholar 

  16. Erovic BM, Al Habeeb A, Harris L, Goldstein DP, Kim D, Ghazarian D, Irish JC (2012) Identification of novel target proteins in sebaceous gland carcinoma. Head Neck. doi:10.1002/hed.23021

  17. Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012;4(5)

  18. Hartman TR, Nicolas E, Klein-Szanto A, Al-Saleem T, Cash TP, Simon MC, Henske EP (2009) The role of the Birt–Hogg–Dube protein in mTOR activation and renal tumorigenesis. Oncogene 28(13):1594–1604

    Article  PubMed  CAS  Google Scholar 

  19. Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, Iwamatsu A, Esposito D, Gillette WK, Hopkins RF 3rd, Hartley JL, Furihata M, Oishi S, Zhen W, Burke TR Jr, Linehan WM, Schmidt LS, Zbar B (2006) Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci U S A. 103(42):15552–15557

    Article  PubMed  CAS  Google Scholar 

  20. van Slegtenhorst M, Khabibullin D, Hartman TR, Nicolas E, Kruger WD, Henske EP (2007) The Birt–Hogg–Dube and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe. J Biol Chem 282(34):24583–24590

    Article  PubMed  Google Scholar 

  21. Hartman TR, Liu D, Zilfou JT, Robb V, Morrison T, Watnick T, Henske EP (2009) The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hum Mol Genet 18(1):151–163

    Article  PubMed  CAS  Google Scholar 

  22. Eng C (2003) PTEN: one gene, many syndromes. Hum Mutat 22(3):183–198

    Article  PubMed  CAS  Google Scholar 

  23. Sansal I, Sellers WR (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22(14):2954–2963

    Article  PubMed  CAS  Google Scholar 

  24. Ponti G (2005) Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol 6(12):980–987

    Article  PubMed  Google Scholar 

  25. Lim TH, Fujikane R, Sano S, Sakagami R, Nakatsu Y, Tsuzuki T, Sekiguchi M, Hidaka M (2012) Activation of AMP-activated protein kinase by MAPO1 and FLCN induces apoptosis triggered by alkylated base mismatch in DNA. DNA Repair (Amst). 11(3):259–266

    Article  PubMed  CAS  Google Scholar 

  26. Kahana M, Grossman E, Feinstein A, Ronnen M, Cohen M, Millet MS (1987) Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol 67(2):175–177

    PubMed  CAS  Google Scholar 

  27. Cocciolone RA, Crotty KA, Andrews L, Haass NK, Moloney FJ (2010) Multiple desmoplastic melanomas in Birt–Hogg–Dube syndrome and a proposed signaling link between folliculin, the mTOR pathway, and melanoma susceptibility. Arch Dermatol 146(11):1316–1318

    Article  PubMed  Google Scholar 

  28. Chung JY, Ramos-Caro FA, Beers B, Ford MJ, Flowers F (1996) Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt–Hogg–Dube syndrome. Int J Dermatol 35(5):365–367

    Article  PubMed  CAS  Google Scholar 

  29. Farrant PB, Emerson R (2007) Letter: hyfrecation and curettage as a treatment for fibrofolliculomas in Birt–Hogg–Dube syndrome. Dermatol Surg 33(10):1287–1288

    Article  PubMed  CAS  Google Scholar 

  30. Gambichler T, Wolter M, Altmeyer P, Hoffman K (2000) Treatment of Birt–Hogg–Dube syndrome with erbium:YAG laser. J Am Acad Dermatol 43(5 Pt 1):856–858

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Our work is supported by grants from the Dutch Cancer Society KWF (KWF UM 2009–4352), the Association for International Cancer Research (AICR 11–0687) and the Annadal Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maurice A. M. van Steensel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vernooij, M., Claessens, T., Luijten, M. et al. Birt–Hogg–Dubé syndrome and the skin. Familial Cancer 12, 381–385 (2013). https://doi.org/10.1007/s10689-013-9600-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-013-9600-8

Keywords

Navigation